Corey Davis, J.D., M.S.P.H., serves as Director of the Network’s Harm Reduction Legal Project. Corey was previously a Senior Attorney at the National Health Law Program (NHeLP), where he helped to advance access to quality health care for low-income and underserved individuals. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania, where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. He previously oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program.
Corey has served as chair of a county board of health, chair of the board of the North Carolina Harm Reduction Coalition, and vice-chair of the North Carolina Harm Public Health Foundation, among other positions. He is a recipient of the International AIDS Society’s Young Investigator Award andhas published extensively in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.
View a collection of research, resources and trainings produced by Corey below.
This webinar focused on the legal and regulatory modifications during COVID-19, how they are being used to increase access treatment for opioid use disorder, and opportunities to permanently increase access to medications.
While states have passed various laws designed to increase access to naloxone, a life-saving opioid overdose reversal medication, none explicitly address the legality of dispensing naloxone that is past its expiration date. This fact sheet discusses whether Georgia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.
This fact sheet discusses whether District of Columbia laws forbid the prescription, dispensing, distribution, possession, or administration of expired naloxone and whether such actions impact the risk of civil liability for medical professionals who prescribe or dispense naloxone or laypeople who distribute or administer it.
The Drug Enforcement Administration (DEA) has temporarily waived or clarified several regulations that may act as barriers to providing life-saving medications to those undergoing treatment for opioid use disorder during the COVID-19 Pandemic. These changes have the potential to dramatically increase access to these medication and the DEA should strongly consider extending many of these changes for the duration of the opioid public health emergency, which will remain even after the threat from COVID-19 subsides.
This fact sheet discusses whether Illinois laws forbids the prescription, dispensing, distribution, possession, or administration of expired naloxone.
The medications methadone and buprenorphine are extremely effective in reducing the harms associated with opioid use disorder. In light of the ongoing public health emergency associated with COVID-19 the federal government has recently taken a number of steps to increase access to these lifesaving medications.
This fact sheet discusses whether Illinois laws forbids the prescription, dispensing, distribution, possession, or administration of expired naloxone.
Overdose “Good Samaritan” laws are theoretically designed to encourage people to call for help in an overdose emergency by providing limited legal immunity to overdose victims and those who seek help for them, but many of these laws currently have limitations that discourage people from seeking help.
Opioid overdose is reversible through the timely administration of the medication naloxone and, where needed, the provision of other emergency care. In an attempt to reverse this epidemic of preventable overdose deaths, every state and the District of Columbia have modified their laws to increase access to naloxone, the standard first-line treatment for opioid overdose.
Although government agencies, nonprofit organizations, clinicians, and advocates have made great strides in reducing harm from substance use, they are often hindered by laws and policies that reflect an outdated, punitive-focused approach to drugs and individuals who use them. Attend this webinar to learn about jail diversion and access to treatment, legal aid, naloxone distribution, and other critical programs and policies to help people with substance use disorder. Continuing legal education credits will be offered with this webinar.
Syringe service programs (SSP) are places where people who inject drugs (PWID) can receive new syringes and other injection equipment and drop off used supplies. They typically also provide other harm reduction and health promotion services including referrals to treatment, hepatitis C and HIV testing, the overdose reversal medication naloxone, and other related services. Nevertheless, SSPs are controversial due to stigma around PWID and many states prohibit the use of state funds for the operation of SSPs.
Supervised consumption spaces (SCS) allow people who use drugs to consume those drugs in a controlled setting, under supervision. SCS provide safe injecting equipment and other health supplies and, in most cases, also provide services including medical care, counseling, and referrals to drug treatment. While many states have taken steps towards authorizing or implementing SCS, the federal government has taken a strong stance against them.
